The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for J Grina


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2.EBI
Array Biopharma
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.EBI
Genentech
Non-oxime pyrazole based inhibitors of B-Raf kinase.EBI
Array Biopharma
The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors.EBI
Array Biopharma, 3200 Walnut Street, Boulder, Co 80301, Usa.
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development.EBI
Array Biopharma
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase.EBI
Array Biopharma
Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase.EBI
Array Biopharma
Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic properties.EBI
Array Biopharma
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase.EBI
Array Biopharma
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors.EBI
Array Biopharma
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships.EBI
Arraybiopharma
Cyanopyrrolidine derivatives as inhibitors for DUBsBDB
Mission Therapeutics
1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereofBDB
Shanghai Institute of Material Medica, Chinese Academy of Sciences
Quaternized amines as sodium channel blockersBDB
Purdue Pharma
Design, synthesis and SAR study of hydroxychalcone inhibitors of human ß-secretase (BACE1).BDB
Shanghai Institute of Material Medica, Chinese Academy of Sciences
Flap modulatorsBDB
Janssen Pharmaceutica
Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.BDB
Smithkline Beecham Pharmaceuticals
Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents.BDB
Northwestern University